COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
NCT04401436
COVID-19, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT Number: NCT03475940
Coagulopathy in cardiac surgery; a quaternary-care academic center experience
Objectives:
Primary:
To determine incidence of coagulopathy after cardiac surgery in Thai people To determine incidence of resternotomy for stop bleeding, morbidity and mortality
Secondary:
To identify risk factors which associated with non-red cell transfusion and coagulopathy
study decide: Retrospective chart review
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Faculty of medicine Siriraj hospital, Bangkok Noi, Bangkok, Thailand
Data to be collected:
Age*, gender* Body weight, height, body mass index* Underlying disease: DM, renal disease*, liver disease* Pre-op. Antiplatelet or anticoagulant* Pre-op coagulogram and platelet count* Emergency or elective surgery Resternotomy or not* Intraoperative blood component Intraoperative factor concentration Dose and timing of antifibrinolytic administration* CPB time* Postoperative body temperature*
*Possible risk factors for non-red cell transfusion
statistic: To assess the relationship between risk factors and non-red cell transfusion a univariate analysis was performed using an unpaired t-test and a Chi-square test.
For higher accuracy regarding the impact of single risk factors, a multiple logistic regression analysis was also performed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
coagulopathy and throbocytopenia
Looking for future studies?
Notify MeMahidol University
Other
Coagulopathy in Cardiac Surgery; a Quaternary-care Academic Center Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401436
COVID-19, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06372483
Cardiovascular Diseases, Coagulation Disorder
Groningen, Netherlands
View Trial DetailsNCT05449834
Cardiovascular Diseases, Coagulopathy
Newcastle, New South Wales, Australia
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial Details